RAG1

Source: Wikipedia, the free encyclopedia.
RAG1
Identifiers
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_000448

NM_009019

RefSeq (protein)

NP_000439
NP_001364206
NP_001364207
NP_001364208
NP_001364209

NP_033045

Location (UCSC)Chr 11: 36.51 – 36.59 MbChr 2: 101.47 – 101.48 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Recombination activating gene 1 also known as RAG-1 is a protein that in humans is encoded by the RAG1 gene.[5]

The RAG1 and RAG2 genes are largely conserved in humans. 55.99% and 55.98% of the encoded amino acids contain no reported variants, respectively.[6]

Function

The protein encoded by this gene is involved in antibody and T-cell receptor V(D)J recombination. RAG-1 is involved in recognition of the DNA substrate, but stable binding and cleavage activity also requires RAG-2. The RAG-1/2 complex recognizes recombination signal sequences (RSSs) that flank the V, D and J regions in the genes that encode the heavy and light chains of antibodies and components of T-cell receptors. The complex binds to the RSSs and nicks the DNA. This leads to the removal of the intervening DNA and the eventual ligation of the V, D and J sequences.[7] Defects in this gene can cause several different diseases.[5]

Clinical significance

Because of these effects, Rag1 deletion is used in mouse models of disease to impair T cell and B cell development, and functionally deletes mature T and B cells from the immune system.[8]

In humans, RAG deficiency was first recognised as a form of immune dysregulation known as

autosomal recessive disease. The disorder is generally identified in infants. Complete loss-of-function in RAG1/2, the main components responsible for V(D)J recombination activity, produces severe immunodeficiency in humans. Hypomorphic RAG variants can retain partial recombination activity[9] and result in a distinct phenotype of combined immunodeficiency with granuloma and/or autoimmunity (CID-G/A),[10][11][12] as well as other milder forms, such as antibody deficiency,[13] Idiopathic CD4+ T lymphopenia [14] or vasculitis.[15] RAG deficiency can be measured by in vitro quantification of recombination activity.[16][17][18] 71 RAG1 and 39 RAG2 variants have been functionally assayed to date (2019) (less than 10% of the potential point mutations that may cause disease). However, top candidate variants have been ranked by their predicted clinical relevance.[6]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000166349Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000061311Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: Recombination activating gene 1".
  6. ^
    PMID 31388879
    .
  7. .
  8. ^ "B6.129S7-Rag1tm1Mom/J Mouse Strain Details". Jackson Laboratories.
  9. S2CID 1527777
    .
  10. .
  11. .
  12. .
  13. .
  14. .
  15. .
  16. .
  17. .
  18. .
This page is based on the copyrighted Wikipedia article: RAG1. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy